(Q52886444)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052893%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

[Vitamin D and multiple sclerosis : the role for risk of disease and treatment] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052893%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052893%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

A Döring

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052893%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

J Dörr

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052893%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

language of work or name

German

0 references

publication date

1 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052893%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052893%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052893%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052893%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

173-189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052893%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00115-012-3645-z

10 March 2020

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

[Projection of the number of multiple sclerosis patients in Germany]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Treatment of multiple sclerosis: current concepts and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Vitamin D: A millenium perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Effects of vitamin D on the peripheral adaptive immune system: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Vitamin D and cancer: a review of molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Cyclic changes of vitamin D and PTH are primarily regulated by solar radiation: 5-year analysis of a German (50 degrees N) population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Immunomodulatory effects of Vitamin D in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Epigenetic reduction in invariant NKT cells following in utero vitamin D deficiency in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Dietary vitamin D3 supplements reduce demyelination in the cuprizone model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

New clues about vitamin D functions in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

1,25-Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

1,25-Dihydroxyvitamin D(3) increases striatal GDNF mRNA and protein expression in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Modulation of the immune system by UV radiation: more than just the effects of vitamin D?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Monthly ambient sunlight, infections and relapse rates in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Multiple sclerosis and solar exposure before the age of 15 years: case—control study in Cuba, Martinique and Sicily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Gestational vitamin D and the risk of multiple sclerosis in offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Timing of birth and risk of multiple sclerosis: population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Seasonal fluctuation of multiple sclerosis births in Sardinia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Seasonal patterns in optic neuritis and multiple sclerosis: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Seasonality of admissions with multiple sclerosis in Scotland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Cytokine profile in patients with multiple sclerosis following vitamin D supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Sun exposure and vitamin D are independent risk factors for CNS demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

Therapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-012-3645-Z

25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis

21 January 2018

1 reference

12 December 2020

Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis

1 reference

12 December 2020

An evaluation of the geographic distribution of multiple sclerosis

1 reference

12 December 2020

Risk assessment for vitamin D

1 reference

12 December 2020

Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women

1 reference

12 December 2020

Safety of vitamin D3 in adults with multiple sclerosis

1 reference

12 December 2020

1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking

1 reference

12 December 2020

1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes.

1 reference

12 December 2020

Vitamin D for the management of multiple sclerosis

1 reference

12 December 2020

Vitamin D status and health correlates among German adults

1 reference

12 December 2020

Multiple actions of steroid hormones--a focus on rapid, nongenomic effects

1 reference

12 December 2020

Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial

1 reference

12 December 2020

1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs

1 reference

12 December 2020

Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis

1 reference

12 December 2020

Season of birth and multiple sclerosis in Sweden

1 reference

12 December 2020

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.

1 reference

12 December 2020

Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis

1 reference

12 December 2020

Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis

1 reference

12 December 2020

10.1007/S00115-012-3645-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052893%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference